Drug · DIN 02484277 · Veterinary
GALLIPRANT
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 12, 2019; first marketed June 12, 2019.
- Drug Identification Number (DIN)
- 02484277
- Company (DIN owner)
- Elanco Canada LimitedGuelph, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Class
- Veterinary
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| GRAPIPRANT | 100 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 8, 2019: NOC 21707New Drug Submission (NDS)
Other DINs named GALLIPRANT
- DIN 02484250 · Marketed
- DIN 02484269 · Marketed